CONMED (CNMD)
(Delayed Data from NYSE)
$51.42 USD
+0.94 (1.86%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $51.42 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, CONMED Corporation has a PEG ratio of 1.71 compared to the Medical - Dental Supplies industry's PEG ratio of 1.69.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CNMD 51.42 +0.94(1.86%)
Will CNMD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CNMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CNMD
Here's Why Conmed (CNMD) is a Strong Value Stock
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
CNMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Conmed (CNMD) is a Strong Momentum Stock
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
Why Conmed (CNMD) is a Top Value Stock for the Long-Term
Other News for CNMD
Is CNMD poised for a decline? 20 Day Moving Average Resistance shows up after slipping 4.29%
CNMD Crossed Above 50 Day Moving Average on September 16
Fell Below 50 Day Moving Average appears for CNMD after 1.73% move
Conmed Director Cashes In on Stock Sale!
Insider Sell: Charles Farkas Sells 2,000 Shares of Conmed Corp (CNMD)